Feedback PLC TexRAD® ordered by Samsung Medical Centre in Seoul

TIDMFDBK

Feedback PLC

10 September 2018

Feedback plc

TexRAD(R) ordered by Samsung Medical Centre in South Korea

Cambridge, UK, 10 September 2018: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, announces that its operating company Feedback Medical Ltd has received an order from its South Korean distributor for TexRAD(R) , its patented image texture analysis technology, for the Samsung Medical Centre in Seoul.

The order came via Feedback's South Korean distributor, Korea Computer Motion ISG ("Korea ISG"). It follows the exclusive distributor arrangement announced on 8 June 2017 granting Korea ISG the ability to sell and distribute TexRAD(R) in South Korea for research purposes, performing advanced analysis of routinely acquired medical diagnostic images, such as CT and MRI scans.

To date, Korea ISG has obtained several orders for Feedback's TexRAD(R) software technology in South Korea. This is the first order from Samsung Medical Centre, one of the nation's leading hospital groups, founded by Samsung Group. Samsung Medical Centre has a strong focus on research, particularly in radiology and oncology.

Dr Balaji Ganeshan, Global Business Development Director of Feedback Medical Ltd, said:

"The order of TexRAD(R) by such a cutting-edge medical facility as the Samsung Medical Centre is a great validation of the capabilities of our technology platform. We are seeing increasing traction within our international distributor network as our reputation grows."

- ENDS -

For further information, please contact:

 
 Feedback plc                                   [phone] 
  Alastair Riddell, Executive Chairman           [e-mail] 
  Lindsay Melvin, CFO 
 Instinctif Partners                            [phone] 
  Rozi Morris/ Deborah Bell/ Phillip Marriage    [e-mail] 
 

Notes to editors

About Feedback plc

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer. Feedback Medical works with customers globally from headquarters in the internationally renowned scientific hub of Cambridge, UK. Its proprietary technologies are TexRAD(R) , the quantitative texture analysis tool and Cadran, a picture archiving communication system (PACS). For more information, see www.fbk.com

About TexRAD(R) quantitative texture analysis

TexRAD(R) is a patent-protected software tool which extracts and quantifies texture features in radiological images, assisting research into all tumour types. In the exciting new field of radiomics, TexRAD(R) uncovers biomarkers in medical images which are invisible to the naked eye. TexRAD(R) has featured in over 100 academic publications, won numerous awards and is currently used in over 50 prestigious institutions worldwide. Feedback Medical recently launched TexRAD(R) Lung, a software tool for the analysis of lung cancer, which is CE marked for clinical use in the EU.

About Korea Computer Motion ISG

Korea Computer Motion ISG, part of ISG plc, has installed and supported MRI/CT 3D processing imaging software to about 120 prominent Korean hospitals for 23 years, and is the largest medical imaging software distribution (sales and service/support) company in South Korea. It is an experienced distributor of medical software from world leading suppliers, with a wide customer base.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

NRAFKODKABKDPCK

(END) Dow Jones Newswires

September 10, 2018 02:00 ET (06:00 GMT)